More about

Memorial Sloan Kettering Cancer Center

News
November 14, 2022
2 min read
Save

Precision medicine for lung cancer expands to less common therapeutic targets

Precision medicine for lung cancer expands to less common therapeutic targets

New treatments for emerging targets have expanded the armamentarium in lung cancer, according to a speaker at Chemotherapy Foundation Symposium.

News
November 08, 2022
1 min read
Save

American Society for Radiation Oncology honors two Gold Medal recipients

American Society for Radiation Oncology honors two Gold Medal recipients

The American Society for Radiation Oncology presented the ASTRO Gold Medal to two of its members.

News
November 04, 2022
8 min watch
Save

Factors predict compliance with payer-led oncology clinical pathways

Factors predict compliance with payer-led oncology clinical pathways

A study presented at this year’s ASCO Quality Care Symposium examined predictors of compliance with payer-led oncology clinical pathways.

News
November 03, 2022
1 min read
Save

FDA approves cobimetinib for histiocytic neoplasms

FDA approves cobimetinib for histiocytic neoplasms

The FDA granted accelerated approval to cobimetinib for treatment of certain patients of histiocytic neoplasms.

News
October 20, 2022
2 min read
Save

Researchers suggest avoiding excisional biopsies of soft tissue sarcoma of the hand

Researchers suggest avoiding excisional biopsies of soft tissue sarcoma of the hand

BOSTON — Excisional biopsies of soft tissue sarcoma of the hand are associated with more positive margins and a longer time to patients’ first intervention vs. incisional/needle biopsies, results of a study showed.

News
September 28, 2022
3 min read
Save

Novel CAR-T effective for most patients with advanced multiple myeloma

Novel CAR-T effective for most patients with advanced multiple myeloma

A chimeric antigen receptor T-cell therapy produced a response rate of 71% among patients with relapsed or refractory multiple myeloma, according to phase 1 study results published in The New England Journal of Medicine.

News
September 26, 2022
2 min read
Save

Immunotherapy combo fails to extend disease-free survival in high-risk kidney cancer

Immunotherapy combo fails to extend disease-free survival in high-risk kidney cancer

The combination of nivolumab and ipilimumab after nephrectomy failed to extend DFS among patients with localized renal cell carcinoma at high risk for relapse, results of the phase 3 CheckMate 914 trial showed.

News
September 13, 2022
3 min read
Save

Multicancer blood test shows efficacy for early cancer detection

Multicancer blood test shows efficacy for early cancer detection

A novel multicancer early detection blood test identified a common signal for more than 50 cancer types and predicted where the signal originated in the body among individuals with undiagnosed cancer.

News
September 01, 2022
3 min read
Save

Radiation oncologist aims to ‘galvanize change’ to improve patient experience

Radiation oncologist aims to ‘galvanize change’ to improve patient experience

Since the beginning of her career, Fumiko Chino, MD, has rooted her work as a radiation oncologist in the patient experience, continually working to improve optimal care for those with cancer.

News
August 30, 2022
4 min read
Save

CAR-T will ‘play a very important role’ in multiple myeloma treatment landscape

CAR-T will ‘play a very important role’ in multiple myeloma treatment landscape

The FDA approval of the first ever chimeric antigen receptor T-cell therapy for multiple myeloma in 2021 laid the groundwork for others to follow.

View more